Commit Biologics
Aarhus, Central Denmark Region, Denmark · Biotechnology, Health Care, Therapeutics
Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.
Key facts
- Headquarters
- Aarhus, Central Denmark Region, Denmark
- Employees
- 20
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- commitbio.com
- Company page
Recent activity at Commit Biologics
- : Commit Biologics Appoints Thomas L. F. Montgomery Andresen as Chief Executive Officer
- : Commit Biologics Appoints Mikkel Wandahl Pedersen as Interim CEO
- : Commit Biologics raised €5.5 million in a seed funding round led by Korys to advance its BiCE platform for cancer treatments.
- : Commit Biologics Appoints Mikkel Wandahl Pedersen as Chief Scientific Officer
- : Commit Biologics secured €16 million in a seed funding led by Bioqube Ventures and Novo Holdings to accelerate the development of their immune system activation technology for cancer and autoimmune disease treatment.
Commit Biologics funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2025 | Seed | $5.7M |
| May 2024 | Seed | $17.3M |
Leadership
- Thomas L. F. Montgomery Andresen, Chief Executive Officer
- Pascal Merchiers, Chief Development Officer
- Mikkel Wandahl Pedersen, Chief Scientific Officer
- Nick Stub Laursen, Associate Founder
Verified email and direct lines for Commit Biologics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Companies similar to Commit Biologics
- BIOVIE INC. · Biotechnology, Health Care, Therapeutics
- Rejuvenation Technologies · Biotechnology, Health Care, Therapeutics
- Aerska · Biotechnology, Health Care, Therapeutics
- Illimis Therapeutics · Biotechnology, Health Care, Therapeutics
- Tessera Defense & Homeland Security Inc. · Biotechnology, Health Care, Therapeutics
About Commit Biologics: questions and answers
What does Commit Biologics do?
Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.
Where is Commit Biologics headquartered?
Commit Biologics is headquartered in Aarhus, Central Denmark Region, Denmark.
How many employees does Commit Biologics have?
Commit Biologics has about 20 employees.
Has Commit Biologics raised funding?
Yes. Fundz has recorded 2 funding events for Commit Biologics. The most recent, Seed of $5.7M, was in Feb 2025.
Who leads Commit Biologics?
Thomas L. F. Montgomery Andresen is a Chief Executive Officer at Commit Biologics.
What is the latest news on Commit Biologics?
On Mar 11, 2026, Commit Biologics Appoints Thomas L. F. Montgomery Andresen as Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy